HPPS‐mediated tau siRNA delivery, facilitated by FUS and MBs, demonstrated excellent tau protein silencing efficacy, supporting hydrogen gene therapy in reducing postoperative hippocampal neuroinflammation and cognitive impairments. This evidence concerns the gene MAPT and Cognitive impairment.